F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Keightley, Margaret C ^a   Brown, Pamela ^a   Jabbour, Henry N ^a   Sales, Kurt J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; PROSTAGLANDIN F2 ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN F2ALPHA RECEPTOR; PROTEIN SERINE THREONINE KINASE; PTGS2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING; UMBILICAL VEIN; CYTOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 77349089990     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-8     Document Type: Article

References (48)

1. Westlake S, Cooper N. Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004. Health Stat Q 2008, (38):33-46.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
3. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventós J. Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 2008, 108(3-5):221-229. 10.1016/j.jsbmb.2007.09.020, 18061438.
4. Jabbour HN, Sales KJ, Smith OP, Battersby S, Boddy SC. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006, 252(1-2):191-200. 10.1016/j.mce.2006.03.025, 2694989, 16701939.
5. Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2000, 2(6):483-490. 10.1038/sj.neo.7900119, 1508090, 11228540.
6. Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids 1996, 55(3):179-183. 10.1016/S0952-3278(96)90095-2, 8931116.
7. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83(3):493-501. 10.1016/0092-8674(95)90127-2, 8521479.
8. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998, 93(5):705-716. 10.1016/S0092-8674(00)81433-6, 9630216.
9. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285(21):1182-1186.
10. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3(6):401-410. 10.1038/nrc1093, 12778130.
11. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977, 14(1):53-65. 10.1016/0026-2862(77)90141-8, 895546.
12. Sales KJ, Boddy SC, Williams AR, Anderson RA, Jabbour HN. F-prostanoid receptor regulation of fibroblast growth factor 2 signalling in endometrial adenocarcinoma cells. Endocrinology 2007, 148(8):3635-3644. 10.1210/en.2006-1517, 17478553.
13. Sales KJ, List T, Boddy SC, Williams AR, Anderson RA, Naor Z, Jabbour HN. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Res 2005, 65(17):7707-7716. 2694301, 16140938.
14. Soufla G, Sifakis S, Spandidos DA. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Cancer Lett 2008, 259(2):146-155. 10.1016/j.canlet.2007.10.002, 18006148.
15. Danielsen T, Rofstad EK. VEGF, bFGF and EGF in the angiogenesis of human melanoma xenografts. Int J Cancer 1998, 76(6):836-841. 10.1002/(SICI)1097-0215(19980610)76:6<836::AID-IJC12>3.0.CO;2-0, 9626350.
16. Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000, 60(17):4932-4938.
17. Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000, 130(3):641-649. 10.1038/sj.bjp.0703327, 1572093, 10821793.
18. Auguste P, Javerzat S, Bikfalvi A. Regulation of vascular development by fibroblast growth factors. Cell Tissue Res 2003, 314(1):157-166. 10.1007/s00441-003-0750-0, 12851809.
19. Konerding MA, Fait E, Dimitropoulou C, Malkusch W, Ferri C, Giavazzi R, Coltrini D, Presta M. Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. Am J Pathol 1998, 152(6):1607-1616. 1858460, 9626064.
20. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 1997, 3(8):887-893. 10.1038/nm0897-887, 9256280.
21. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980, 288(5791):551-556. 10.1038/288551a0, 6160403.
22. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86(3):353-364. 10.1016/S0092-8674(00)80108-7, 8756718.
23. Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8(6):464-478. 10.1038/nrm2183, 17522591.
24. Kanda S, Hodgkin MN, Woodfield RJ, Wakelam MJ, Thomas G, Claesson-Welsh L. Phosphatidylinositol 3'-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J Biol Chem 1997, 272(37):23347-23353. 10.1074/jbc.272.37.23347, 9287347.
25. Sulpice E, Bryckaert M, Lacour J, Contreres JO, Tobelem G. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood 2002, 100(9):3087-3094. 10.1182/blood.V100.9.3087, 12384403.
26. Peng CY, Pan SL, Lee KH, Bastow KF, Teng CM. Molecular mechanism of the inhibitory effect of KS-5 on bFGF-induced angiogenesis in vitro and in vivo. Cancer Lett 2008, 263(1):114-121. 10.1016/j.canlet.2007.12.028, 18243528.
27. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 1998, 140(5):1255-1263. 10.1083/jcb.140.5.1255, 2132684, 9490736.
28. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB. Utilization of distinct signalling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 2000, 275(7):5096-5103. 10.1074/jbc.275.7.5096, 10671553.
29. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139. full_text, 9561267.
30. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609. 10.1146/annurev.cellbio.13.1.513, 9442882.
31. Kilarski WW, Jura N, Gerwins P. Inactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeleton. Exp Cell Res 2003, 291(1):70-82. 10.1016/S0014-4827(03)00374-4, 14597409.
32. Koh W, Sachidanandam K, Stratman AN, Sacharidou A, Mayo AM, Murphy EA, Cheresh DA, Davis GE. Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signalling cascade downstream of Cdc42 activation. J Cell Sci 2009, 122(11):1812-1822. 10.1242/jcs.045799, 19435802.
33. Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007, 12(1):9-22. 10.1016/j.ccr.2007.05.008, 17613433.
34. Lee DF, Hung MC. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 2007, 6(24):3011-3014.
35. Drakos E, Rassidakis GZ, Medeiros LJ. Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas. Expert Rev Mol Med 2008, 10:e4. 10.1017/S1462399408000586, 18241520.
36. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 2006, 203(4):941-951. 10.1084/jem.20052124, 2118273, 16567391.
37. Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 2004, 15(8):398-404. 2694300, 15380812.
38. Qian RZ, Yue F, Zhang GP, Hou LK, Wang XH, Jin HM. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor. Chin Med J (Engl) 2008, 121(24):2599-2603.
39. Finetti F, Solito R, Morbidelli L, Giachetti A, Ziche M, Donnini S. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1. J Biol Chem 2008, 283(4):2139-2146. 10.1074/jbc.M703090200, 18042549.
40. Rao R, Redha R, Macias-Perez I, Su Y, Hao C, Zent R, Breyer MD, Pozzi A. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem 2007, 282(23):16959-16968. 10.1074/jbc.M701214200, 17401137.
41. Tamura K, Sakurai T, Kogo H. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vascul Pharmacol 2006, 44(6):411-416. 10.1016/j.vph.2006.02.009, 16651031.
42. Taylor L, Foxall T, Auger K, Heinsohn C, Polgar P. Comparison of prostaglandin synthesis by endothelial cells from blood vessels originating in the rat, baboon, calf and human. Atherosclerosis 1987, 65(3):227-236. 10.1016/0021-9150(87)90038-4, 3113442.
43. Sales KJ, Milne SA, Williams AR, Anderson RA, Jabbour HN. Expression, localization, and signalling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signalling pathways. J Clin Endocrinol Metab 2004, 89(2):986-993. 10.1210/jc.2003-031434, 14764825.
44. Sales KJ, Battersby S, Williams AR, Anderson RA, Jabbour HN. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signalling pathway. J Clin Endocrinol Metab 2004, 89(12):6112-6118. 10.1210/jc.2004-0892, 15579767.
45. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002, 62(2):424-432. 2694304, 11809691.
46. Battersby S, Sales KJ, Williams AR, Anderson RA, Gardner S, Jabbour HN. Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway. Hum Reprod 2007, 22(1):36-44. 10.1093/humrep/del328, 2694993, 16905765.
47. Ledingham MA, Denison FC, Kelly RW, Young A, Norman JE. Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. Mol Hum Reprod 1999, 5(10):973-982. 10.1093/molehr/5.10.973, 10508227.
48. Denison FC, Calder AA, Kelly RW. The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. Am J Obstet Gynecol 1999, 180(3 Pt 1):614-620. 10.1016/S0002-9378(99)70263-2, 10076137.